Teladoc Health has developed a Cardiometabolic Health Value Model, a theoretical economic model to estimate the return on investment (ROI) and value on investment (VOI) of its chronic care multi-condition programs. Teladoc recently commissioned Milliman to conduct a review of this methodology to determine its appropriateness for estimating the ROI and VOI of the programs. This report:

• Provides an overview of Teladoc Health's chronic care programs
• Describes the methodology employed to estimate the ROI and VOI for these programs
• Discusses potential limitations of the methodology 
• Outlines important caveats and limitations of Milliman’s review of the ROI and VOI methodology

This report was commissioned by Teladoc Health.